Trial Information
A Prospective Study of Clinical Outcomes for the Pathwork® Tissue of Origin Test
Inclusion Criteria:
- their physician ordered or intends to order a Pathwork® TOO Test between May 2012 and
December 2013
- the patient is ≥ 18 years of age
- the patient has given informed consent (online or verbal)
- the patient is able to understand English.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Survival
Outcome Time Frame:
2 years
Safety Issue:
No
Principal Investigator
John Hornberger, MD MS
Investigator Role:
Principal Investigator
Investigator Affiliation:
Cedar Associates LLC
Authority:
United States: Institutional Review Board
Study ID:
10043P
NCT ID:
NCT01649453
Start Date:
May 2012
Completion Date:
February 2013
Related Keywords:
- Neoplasm Metastasis
- Neoplasms
- Neoplasm Metastasis
- Neoplastic Processes
- Pathologic Processes
- Neoplasms
- Neoplasm Metastasis
Name | Location |
Cedar Associates LLC |
Menlo Park, California 94025 |